“One day we see a gap up and another day we see a gap down. So, market is directionless and choppy. So, in such kind of a market, fmcg space and pharma space is doing pretty well, so I like that space,” says Aditya Arora, Adlytick.This has been a very difficult last one, one-and-a-half month. … Read more
“We see good opportunities in the pharma space, especially pharma generic exporter companies which have not performed well for many years. I think there are opportunities in the less popular sectors where money can be made over the next two to three years,” says Abhay Agarwal, Piper Serica.Which stocks are you probably going to keep … Read more
“So, given that kind of environment, I believe that Indoco Remedies is a stock which is going very cheap, available at cheap valuations and the management is pretty well embedded in the business, they have been around for 30 years,” says Vinit Bolinjkar, Ventura Securities.A view on the pharma space in AstraZeneca, Lupin, Laurus, Zydus … Read more
“Important support for Nifty Small Cap Index is 18,000 and 17,800 to 18,000 is the important demand level for Small Cap Index,” says Aditya Arora, Adlytick.How did you read the opening and the recovery thereabout today both Nifty Bank Nifty and which is largecap universe as well as the smallcap and midcap universe?Aditya Arora: The … Read more
“I think this is going to be the overall range for the next two to three days, that is the 23,000 between and 23,500 on the higher side,” says Soni Patnaik, JM Financial Services.What is your understanding of the market mood right now? We scaled a fresh record high. Are we headed to 23,500 now? … Read more
